Table 2.
Baseline characteristics of NSCLC patients new to SKCCC.
| Characteristic | Ineligible for trials (n = 77) | Eligible for trials (n = 76) | Total (n = 153) | P value |
|---|---|---|---|---|
| Age, y <60 60–69 > = 70 |
25 (32.5) 28 (36.4) 24 (31.2) |
31 (40.8) 28 (36.8) 17 (22.4) |
56 (36.6) 56 (36.6) 41 (26.8) |
0.40 |
| Sex, % Male Female |
43 (55.8) 34 (44.2) |
33 (43.4) 43 (56.6) |
76 (49.7) 77 (50.3) |
0.12 |
| Race White Black Other |
50 (64.9) 18 (23.4) 9 (11.7) |
59 (77.6) 9 (11.8) 8 (10.5) |
109 (71.2) 27 (17.6) 17 (11.1) |
0.15 |
| Smoking status Never Former Current |
17 (22.1) 36 (46.8) 24 (31.2) |
23 (30.3) 49 (64.5) 4 (5.3) |
40 (26.1) 85 (55.6) 28 (18.3) |
<0.0001 |
| Stage and line of treatment Stage 1 or 2 Stage 3 Stage 4: first line therapy Stage 4: second line therapy or greater |
12 (15.6) 24 (31.2) 23 (29.9) 18 (23.4) |
3 (4.0) 3 (4.0) 32 (42.1) 38 (50.0) |
15 (9.8) 27 (17.6) 55 (35.9) 56 (36.6) |
<0.0001 |
| Type of initial appointment Diagnosis or treatment Consult only |
41 (53.3) 36 (46.8) |
26 (34.2) 50 (65.8) |
67 (43.8) 86 (56.2) |
0.02 |